Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+
Clinical trial NCT02593708 · TERMINATED
Trial details
- NCT number
- NCT02593708
- Sponsor
- Michelle Melisko
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-03
- Primary completion
- 2017-01-05
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.